These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13518169)

  • 21. The isolation of Brucella abortus from milk. I. Biological examination (guinea-pig inoculation).
    Farrell ID; Robertson L
    Mon Bull Minist Health Public Health Lab Serv; 1967; 26():52-9. PubMed ID: 4962743
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunity to brucella infection.
    Elberg SS
    Medicine (Baltimore); 1973 Jul; 52(4):339-56. PubMed ID: 4198657
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies of experimental brucellosis. Brucella abortus infection in the male guinea pig and effect of sensitization on various organs.
    Ueda K; Imaizumi K
    Nihon Juigaku Zasshi; 1969 Dec; 31(6):287-302. PubMed ID: 4983853
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of simultaneous inoculation of B. abortus strain 19 and foot-and-mouth disease vaccines on immunity against brucellosis in the guinea pig].
    García-Carrillo C
    Rev Asoc Argent Microbiol; 1978; 10(1):1-7. PubMed ID: 210482
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of laboratory animals in the potency test of Brucella abortus S.19 vaccine. Response of guinea-pigs to graduated doses of vaccine and challenge.
    Thornton DH; Muskett JC
    J Comp Pathol; 1972 Apr; 82(2):201-8. PubMed ID: 4625200
    [No Abstract]   [Full Text] [Related]  

  • 27. Selection analysis of populations of vaccine strains of Brucella.
    Vershilova PA; Ostrovskaya NN; Grekova NA
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(1):34-46. PubMed ID: 4958780
    [No Abstract]   [Full Text] [Related]  

  • 28. [Passive transference of bacterial allergy from guinea pigs infected with Brucella abortus].
    METAXAS-BUHLER M
    Int Arch Allergy Appl Immunol; 1951; 1(4):325-32. PubMed ID: 14823761
    [No Abstract]   [Full Text] [Related]  

  • 29. [The course of Brucella infection in guinea pigs infected with Brucella isolated from reindeer].
    Grekova NA; Gubina EA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Apr; 42(4):92-6. PubMed ID: 4957696
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on an immunogenic agent against Brucella abortus. I. Titrations of a new soluble immunogenic agent against experimental infections in guinea pigs.
    HOAG WG; ALLEN RC
    Am J Vet Res; 1959 Jan; 20():162-5. PubMed ID: 14402120
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge.
    Lalsiamthara J; Lee JH
    Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of the immunobiological properties of live brucellosis vaccines.
    Salmakov KM; Fomin AM; Plotnikova EM; Safina GM; Galimova GM; Salmakova AV; Ivanov AV; Panin AN; Sklyarov OD; Shumilov KV; Klimanov AI
    Vaccine; 2010 Oct; 28 Suppl 5():F35-40. PubMed ID: 20362201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro sensitivity to brucellergen of leucocytes from guinea pigs experimentally infected with Brucella abortus.
    DARLINGTON RW; SCHERAGO M
    J Infect Dis; 1960; 106():106-10. PubMed ID: 13814133
    [No Abstract]   [Full Text] [Related]  

  • 34. [ISOLATION OF BRUCELLOSIS PATHOGEN FROM THE GUINEA PIG EYE FOLLOWING EXTRAOCULAR INFECTION].
    KISELEVA VM; LOPATUKHINA LG; USMANOVA FI
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():120-5. PubMed ID: 14070193
    [No Abstract]   [Full Text] [Related]  

  • 35. Leukocyte migration inhibition by a specific antigen in human brucellosis.
    Nyerges G; Telegdy L
    Infection; 1975; 3(4):213-6. PubMed ID: 812829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physico-chemical properties of microbial antigens and the immuno-allergic tests].
    Beklemishev ND; Sukhodoeva GS; Bul'vakhter IaL; Shin NG
    Biull Eksp Biol Med; 1978 Mar; 85(3):322-5. PubMed ID: 96888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active immunization with Brucella abortus S19 phage lysate elicits serum IgG that protects guinea pigs against virulent B. abortus and protects mice by passive immunization.
    Jain L; Rawat M; Ramakrishnan S; Kumar B
    Biologicals; 2017 Jan; 45():27-32. PubMed ID: 27913028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and histological features of brucellin skin test responses in Brucella suis biovar 2 infected pigs.
    Dieste-Pérez L; Barberán M; Muñoz PM; Moriyón I; Blasco JM
    Vet Immunol Immunopathol; 2015 Jan; 163(1-2):77-85. PubMed ID: 25480681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractionation of sera from guinea pigs at different stages of Brucella abortus infection.
    CONDE E; POMALES-LEBRON A; CANCIO M
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):640-2. PubMed ID: 13614449
    [No Abstract]   [Full Text] [Related]  

  • 40. THE CHEMICAL BASIS OF THE VIRULENCE OF BRUCELLA ABORTUS. VI. STUDIES ON IMMUNITY AND INTRACELLULAR GROWTH.
    MACRAE RM; SMITH H
    Br J Exp Pathol; 1964 Dec; 45(6):595-603. PubMed ID: 14245159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.